PURPOSE: The association of single nucleotide polymorphisms of components of the complement alternative pathway with the risk of age-related macular degeneration (AMD) indicates that complement signaling plays an important role in retinal physiology. How genetic variation leads to retinal degeneration is unknown. It has been assumed that complement activation augments immune responses, which in turn initiate AMD pathogenesis. To better understand the relationship between complement and the outer retina, we examined mice lacking the main complement component C3 and the receptors for complement activation fragments C3a (C3aR) and/or C5a (C5aR). METHODS: Complement mutant mice were studied along with wild-type (WT) littermates from 6 weeks to 14 months of age. Strobe flash electroretinography (ERG) was used to examine outer retinal function and a dc-ERG technique was used to measure ERG components generated by the retinal pigment epithelium. Retinas were examined by histology, immunohistochemistry, and biochemistry. RESULTS: Mice lacking C3aR and/or C5aR developed early onset and progressive retinal degeneration, accompanied by cleaved caspase-3 upregulation. Genetic deletion of C3aR and/or C5aR led to cell-specific defects that matched the cellular localization of these receptors in the WT retina. Compared to WT, C3aR(-/-) and C3aR(-/-)C5aR(-/-) mice showed increased retinal dysfunction upon light exposure. C3aR(-/-)C5aR(-/-) mice immunized with 4-hydroxynonenal-adducted protein developed severe retinal impairment unrelated to immune response. CONCLUSIONS: C3aR- and C5aR-mediated signaling was necessary to maintain normal retinal function and structure. These receptors may be important biomarkers for predicting retinal degeneration including AMD.
PURPOSE: The association of single nucleotide polymorphisms of components of the complement alternative pathway with the risk of age-related macular degeneration (AMD) indicates that complement signaling plays an important role in retinal physiology. How genetic variation leads to retinal degeneration is unknown. It has been assumed that complement activation augments immune responses, which in turn initiate AMD pathogenesis. To better understand the relationship between complement and the outer retina, we examined mice lacking the main complement component C3 and the receptors for complement activation fragments C3a (C3aR) and/or C5a (C5aR). METHODS: Complement mutant mice were studied along with wild-type (WT) littermates from 6 weeks to 14 months of age. Strobe flash electroretinography (ERG) was used to examine outer retinal function and a dc-ERG technique was used to measure ERG components generated by the retinal pigment epithelium. Retinas were examined by histology, immunohistochemistry, and biochemistry. RESULTS:Mice lacking C3aR and/or C5aR developed early onset and progressive retinal degeneration, accompanied by cleaved caspase-3 upregulation. Genetic deletion of C3aR and/or C5aR led to cell-specific defects that matched the cellular localization of these receptors in the WT retina. Compared to WT, C3aR(-/-) and C3aR(-/-)C5aR(-/-) mice showed increased retinal dysfunction upon light exposure. C3aR(-/-)C5aR(-/-) mice immunized with 4-hydroxynonenal-adducted protein developed severe retinal impairment unrelated to immune response. CONCLUSIONS:C3aR- and C5aR-mediated signaling was necessary to maintain normal retinal function and structure. These receptors may be important biomarkers for predicting retinal degeneration including AMD.
Authors: Jinbo Liu; Feng Lin; Michael G Strainic; Fengqi An; Robert H Miller; Cengiz Z Altuntas; Peter S Heeger; Vincent K Tuohy; M Edward Medof Journal: J Immunol Date: 2008-05-01 Impact factor: 5.422
Authors: Claire E Bamberg; Charles R Mackay; Hyun Lee; David Zahra; Jenny Jackson; Yun Si Lim; Peter L Whitfeld; Stewart Craig; Erin Corsini; Bao Lu; Craig Gerard; Norma P Gerard Journal: J Biol Chem Date: 2009-12-31 Impact factor: 5.157
Authors: Michael G Strainic; Jinbo Liu; Danping Huang; Fengqi An; Peter N Lalli; Nasima Muqim; Virginia S Shapiro; George R Dubyak; Peter S Heeger; M Edward Medof Journal: Immunity Date: 2008-03-06 Impact factor: 31.745
Authors: Tiarnan D Keenan; Elvira Agrón; Amitha Domalpally; Traci E Clemons; Freekje van Asten; Wai T Wong; Ronald G Danis; SriniVas Sadda; Philip J Rosenfeld; Michael L Klein; Rinki Ratnapriya; Anand Swaroop; Frederick L Ferris; Emily Y Chew Journal: Ophthalmology Date: 2018-07-27 Impact factor: 12.079
Authors: Sheri L Peterson; Yiqing Li; Christina J Sun; Kimberly A Wong; Kylie S Leung; Silmara de Lima; Nicholas J Hanovice; Kenya Yuki; Beth Stevens; Larry I Benowitz Journal: J Neurosci Date: 2021-08-20 Impact factor: 6.167